524400 — Ishita Drugs And Industries Income Statement
0.000.00%
Last trade - 00:00- IN₹227.65m
- IN₹160.48m
- IN₹146.60m
Annual income statement for Ishita Drugs And Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 141 | 121 | 152 | 150 | 147 |
| Cost of Revenue | |||||
| Gross Profit | 39.2 | 35.2 | 38.9 | 43.2 | 43.5 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 131 | 114 | 144 | 141 | 140 |
| Operating Profit | 9.61 | 6.32 | 7.97 | 8.92 | 6.66 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 10.4 | 7.79 | 9.87 | 11.6 | 10.8 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 8.05 | 5.77 | 7.49 | 8.68 | 7.79 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 8.05 | 5.77 | 7.49 | 8.68 | 7.79 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 8.05 | 5.77 | 7.49 | 8.68 | 7.79 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.69 | 1.93 | 2.5 | 2.9 | 2.6 |